|
|
||||||||
Clinical Chemistry, Vol 38, 2405-2410, Copyright © 1992 by American Association for Clinical Chemistry
K Hyland and PT Clayton
Department of Child Health, Institute of Child Health, London, UK.
Aromatic L-amino acid decarboxylase (EC. 4.1.1.28) deficiency is a newly described inborn error of metabolism that affects serotonin and dopamine biosynthesis. The major biochemical markers for this disease are increases of L-dopa, 3-methoxytyrosine, and 5-hydroxytryptophan in urine, plasma, and cerebrospinal fluid together with decreased cerebrospinal fluid concentrations of homovanillic acid and 5- hydroxyindoleacetic acid. In addition, concentrations of vanillactic acid are increased in the urine. Specific HPLC and gas chromatography- mass spectrometry methods are described that permit the identification and measurement of these metabolites in the above body fluids. Simplified assays for human plasma L-dopa decarboxylase and liver L- dopa and 5-hydroxytryptophan decarboxylase, used to demonstrate the enzyme deficiency, are also reported.
The following articles in journals at HighWire Press have cited this article:
![]() |
P.-C. Fan, W.-J. Huang, and L.-C. Chiou Intractable Chronic Motor Tics Dramatically Respond to Clerodendrum inerme (L) Gaertn J Child Neurol, July 1, 2009; 24(7): 887 - 890. [Abstract] [PDF] |
||||
![]() |
K. Hyland Clinical Utility of Monoamine Neurotransmitter Metabolite Analysis in Cerebrospinal Fluid Clin. Chem., April 1, 2008; 54(4): 633 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Matsuda, H. Hayashi, S. Miyatake, T. Kuroiwa, and H. Kagamiyama Instability of the Apo Form of Aromatic L-Amino Acid Decarboxylase In Vivo and In Vitro: Implications for the Involvement of the Flexible Loop That Covers the Active Site J. Biochem., January 1, 2004; 135(1): 33 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hyland and L. A. Arnold Value of Lumbar Puncture in the Diagnosis of Genetic Metabolic Encephalopathies J Child Neurol, November 1, 1999; 14(1_suppl): S9 - S15. [Abstract] [PDF] |
||||
![]() |
K. J. Swoboda, K. Hyland, D. S. Goldstein, K. C. K. Kuban, L. A. Arnold, C. S. Holmes, and H. L. Levy Clinical and therapeutic observations in aromatic L-amino acid decarboxylase deficiency Neurology, October 1, 1999; 53(6): 1205 - 1205. [Abstract] [Full Text] |
||||
![]() |
P. J. Blanchet, J. Fang, K. Hyland, L. A. Arnold, M. M. Mouradian, and T. N. Chase Short-term effects of high-dose 17{beta}-estradiol in postmenopausal PD patients: A crossover study Neurology, July 1, 1999; 53(1): 91 - 91. [Abstract] [Full Text] |
||||
![]() |
A. Maller, K. Hyland, S. Milstien, I. Biaggioni, and I. J. Butler Aromatic L-Amino Acid Decarboxylase Deficiency: Clinical Features, Diagnosis, and Treatment of a Second Family J Child Neurol, September 1, 1997; 12(6): 349 - 354. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |